Import guide

Importing APIs, excipients, intermediates and contract manufacture from India

Active pharmaceutical ingredients, excipients and pharmaceutical intermediates sold as bulk material against a specification, plus CDMO and CMO contract-manufacturing capability sold as access to a site and a process. Finished dosage forms bound for the United States are explicitly excluded: a finished drug product needs an ANDA or NDA holder of record, state-level wholesale distributor licensing and DSCSA serialization at the unit level, none of which Indiasay holds or arranges. What a buyer qualifies here is the substance and the site, not a brand.